Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Stoma Discharge Reinfusion After Sphincter Preservation for Middle and Low Rectal Cancer [NA]

View source ↗

Summary

A clinical trial (NCT05461248) evaluating stoma discharge reinfusion after sphincter-preserving surgery for middle and low rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Rectal Cancer | NA | Status: COMPLETED